Mono Pharmacare IPO will open for subscription from 28 August 2023. The company aims for an issue size of ₹14.84 Cr through this IPO.
Company Overview
| Full name | Mono Pharmacare Limited |
| Sector | Trading |
| Industry | Trading |
| Company Website | https://monopharmacareltd.com/ |
About Company
Incorporated in 1994, Mono Pharmacare is engaged in the business of marketing and distribution of pharmaceutical products. The company works with contract manufacturers to produce pharmaceutical products and sells them under its brand name “DLS Export”. The company acquired DLS Export on 15 December 2022, for an aggregate consideration of INR 6.09 crores, in order to grow its product portfolio in selected therapeutic areas.
As of 28 February 2023, Mono Pharmacare is dealing with (distributors and stockists) 168 pharmaceutical companies, and also, it is also connected with 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers. The company’s total number of employees is 81.
Mono Pharmacare offers Health Care products, Antibiotic medicines, Antifungal medicines, Anti-Cough and Cold Allergic medicines, Nutraceutical medicines, Analgesic and antipyretic medicines, Antacid and antiemetics medicines, Cardiac – Diabetic medicines, and Cosmocare products.
The Objective of the Issue
- To meet the working capital requirements,
- General corporate purposes, and
- To meet the issue expenses.
IPO Timetable
| IPO Opening date | 28 August 2023 |
| IPO Closing | 30 August 2023 |
| Basis of Allotment | 04 September 2023 |
| Initiation Refund | 05 September 2023 |
| Credit to Demat Account | 06 September 2023 |
| Listing Date | 07 September 2023 |
IPO details
| Issue type | FiBook Built Issue IPO |
| IPO issue size | ₹14.84 Cr – 5,300,000 shares |
| Fresh Issue | ₹14.84 Cr – 5,300,000 shares |
| Offer for sale | Nil |
| Face value | ₹10 per share |
| Price Band | ₹26 to ₹28 per share |
| Lot size | 4000 Shares |
| Market Maker portion | 276,000 shares |
| Listing Exchange | NSE SME |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹112,000 |
| Retail (Max) | 1 | 4000 | ₹112,000 |
| HNI (Min) | 2 | 8,000 | ₹224,000 |
Reservation Details
| Anchor Investor Shares Offered | – |
| Market Maker Shares Offered | 276,000 (5.21%) |
| QIB Shares Offered | 500,000 (9.43%) |
| NII (HNI) Shares Offered | 2,260,000 (42.64%) |
| Retail Shares Offered | 2,264,000 (42.72%) |
| Total Shares Offered | 5,300,000 (100%) |
Financial Performance
| FY 2021 | FY 2022 | 1Apr – 16 Oct FY 2023 | 17 Oct – 31 Mar FY 2023 | |
| Revenue | 2,826.61 | 3,698.30 | 2,538.94 | 3,308.70 |
| Expenses | 2,820.92 | 3,655.18 | 2,510.71 | 3,182.98 |
| Net income | 9.51 | 35.09 | 28.84 | 94.36 |
Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 0.20 | 0.75 | 1.99 |
| PE ratio | – | – | 13.07 – 14.07 |
| RONW (%) | 2.57 | 8.21 | 9.01 |
| NAV | 7.93 | 9.18 | 19.92 |
| ROCE (%) | 17.75 | 22.33 | 10.34 |
| EBITDA (%) | 3.00 | 3.47 | 5.07 |
| Debt/Equity | 1.65 | 1.51 | 2.92 |
Company Promoters
- Panilam Lakhatariya
- Supal Lakhatariya
Promoter Holding
| Pre Issue Share Holding | 81.02% |
| Post Issue Share Holding | – |
Lead Manager(s)
UNISTONE CAPITAL PRIVATE LIMITED
A/305, Dynasty Business Park, Andheri Kurla Road,
Andheri East, Mumbai 400059, Maharashtra
Phone:+91 98200 57533
Email: mb@unistonecapital.com
Website: www.unistonecapital.com
IPO Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East, Mumbai – 400 093
Phone: +91 22 6263 8200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Contact Details
MONO PHARMACARE LIMITED
1A, Krinkal Apartment Opp. Mahalaxmi Temple,
Paldi Ahmedabad -380007, Gujarat
Phone: +91-99780 41356
E-mail: cs@monopharmacareltd.com
Website: www.monopharmacareltd.com
Allotment Status
Mono Pharmacare IPO allotment status will be available on Bigshare Services’ website. Click on this link to get allotment status.
Final thoughts
Mono Pharmacare IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. study well about the company and subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing
